Xanthinol Nicotinate Injection
Function and Efficacy
Pharmacological effects: Clinical trials and animal experiments have confirmed that nicotinic acid xanthinol has a series of pharmacological effects: reducing peripheral vascular resistance, increasing cardiac output, reducing venous pressure, activating fibrinolysis, reducing fibrinogen levels, preventing platelet aggregation, promoting the synthesis of pyrimidine nucleosides (NAD and NADP), increasing the concentration of adenine nucleosides (AMP, ADP and ATP), and finally hindering lipolysis and reducing elevated cholesterol and triglyceride levels. Toxicological studies: The LD50 of nicotinic acid xanthinol for mice is 540 mg/kg intravenous injection; the LD50 of nicotinic acid xanthinol for rats is 750 mg/kg intravenous injection; the LD50 of nicotinic acid xanthinol for rabbits is 539 mg/kg intravenous injection. Due to its low toxicity, it is not suitable for oral administration of mice.
Ingredients
Each ampoule contains 300 mg of XanthinolNicotinate
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Xanthinol nicotinateIngredients |
Reduce peripheral vascular resistance, increase cardiac output, reduce venous pressure, activate fibrinolysis, reduce fibrinogen levels, prevent platelet aggregation, promote the synthesis of pyrimidine nucleosides (NAD and NADP), increase the concentration of adenine nucleosides (AMP, ADP and ATP), hinder lipolysis, and reduce elevated cholesterol and triglyceride levels More |
437-74-1 | 9 |
Appearance
This product is a colorless clear liquid
Indication
Peripheral vascular circulatory disorders
Usage and Dosage
Intramuscular or intravenous injection. 1 ampoule each time, 1 to 2 times a day. Intravenous injection should be slow, and the patient should not lie down. Or use according to doctor's advice.
Adverse Reactions
- Occasionally, there is a feeling of fever or hot flashes in the upper body, which will subside within 10 to 20 minutes after stopping the drug. Reducing the dose can reduce adverse reactions. - Very few patients will have stomach discomfort, which can be relieved by drinking a small amount of milk.
Precautions
- Patients with acute hemorrhagic diseases are prohibited from using this product. - Patients with myocardial infarction, mitral stenosis and heart failure with compensatory dysfunction are prohibited from using this product. - Patients with acute hemorrhagic cerebrovascular disease are prohibited from using this product. - Patients who are allergic to the ingredients of this product (including excipients) are prohibited from using this product.
Drug Interactions
The simultaneous administration of ganglion blockers (such as fensulfamethoxazole, mecamylamine, panpirdine, anxetine) and sympatholytic drugs (such as prazosin, doxamitrine, ergot alkaloids) should be avoided. The combined use of ethanol, coffee and hot drinks leads to an aggravation of the reaction, and the observed consequences are such as skin redness.
Storage
Keep in a sealed container
Packaging Specification
2ml:0.3g
Manufacturer
Jiangsu Langou Pharmaceutical Co., Ltd.
-
Founded in:
2013-06-21 -
Address:
No. 1, Langou Road, Xuzhou Industrial Park, Jiangsu -
Tax NO.:
91320305071075704T -
Registered Funds:
100 million yuan -
Email: